These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17493774)

  • 41. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents.
    Riggs MM; Sethi AK; Zabarsky TF; Eckstein EC; Jump RL; Donskey CJ
    Clin Infect Dis; 2007 Oct; 45(8):992-8. PubMed ID: 17879913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium difficile: a reemerging pathogen.
    Calfee DP
    Geriatrics; 2008 Sep; 63(9):10-21. PubMed ID: 18763846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile colitis.
    Efron PA; Mazuski JE
    Surg Clin North Am; 2009 Apr; 89(2):483-500, x. PubMed ID: 19281896
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neonatal piglet losses associated with Escherichia coli and Clostridium difficile infection in a Slovakian outdoor production unit.
    Nagy J; Bilkei G
    Vet J; 2003 Jul; 166(1):98-100. PubMed ID: 12788023
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.
    Ochsner UA; Bell SJ; O'Leary AL; Hoang T; Stone KC; Young CL; Critchley IA; Janjic N
    J Antimicrob Chemother; 2009 May; 63(5):964-71. PubMed ID: 19251726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.
    Péchiné S; Janoir C; Boureau H; Gleizes A; Tsapis N; Hoys S; Fattal E; Collignon A
    Vaccine; 2007 May; 25(20):3946-54. PubMed ID: 17433506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of necrotic enteritis in piglets by vaccination of pregnant gilts with a Clostridium perfringens type C and D bacterin-toxoid.
    Kelnerić Z; Naglić T; Udovicić I
    Vet Med (Praha); 1996 Nov; 41(11):335-8. PubMed ID: 9036619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of virulence genes of Clostridium difficile by multiplex PCR.
    Antikainen J; Pasanen T; Mero S; Tarkka E; Kirveskari J; Kotila S; Mentula S; Könönen E; Virolainen-Julkunen AR; Vaara M; Tissari P
    APMIS; 2009 Aug; 117(8):607-13. PubMed ID: 19664132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Infection control measures to limit the spread of Clostridium difficile.
    Vonberg RP; Kuijper EJ; Wilcox MH; Barbut F; Tüll P; Gastmeier P; ; ; van den Broek PJ; Colville A; Coignard B; Daha T; Debast S; Duerden BI; van den Hof S; van der Kooi T; Maarleveld HJ; Nagy E; Notermans DW; O'Driscoll J; Patel B; Stone S; Wiuff C
    Clin Microbiol Infect; 2008 May; 14 Suppl 5():2-20. PubMed ID: 18412710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The emergence of Clostridium difficile as a pathogen of food animals.
    Songer JG
    Anim Health Res Rev; 2004 Dec; 5(2):321-6. PubMed ID: 15984348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain.
    Zhang K; Zhao S; Wang Y; Zhu X; Shen H; Chen Y; Sun X
    Anaerobe; 2015 Dec; 36():49-52. PubMed ID: 26461425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection of hamsters with historical and epidemic BI types of Clostridium difficile.
    Razaq N; Sambol S; Nagaro K; Zukowski W; Cheknis A; Johnson S; Gerding DN
    J Infect Dis; 2007 Dec; 196(12):1813-9. PubMed ID: 18190262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of clinical, microbiologic, and clinicopathologic findings in horses positive and negative for Clostridium difficile infection.
    Ruby R; Magdesian KG; Kass PH
    J Am Vet Med Assoc; 2009 Mar; 234(6):777-84. PubMed ID: 19284345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078.
    Goorhuis A; Bakker D; Corver J; Debast SB; Harmanus C; Notermans DW; Bergwerff AA; Dekker FW; Kuijper EJ
    Clin Infect Dis; 2008 Nov; 47(9):1162-70. PubMed ID: 18808358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clostridium difficile infection in solid organ transplant recipients.
    Riddle DJ; Dubberke ER
    Curr Opin Organ Transplant; 2008 Dec; 13(6):592-600. PubMed ID: 19060548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
    Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clostridium difficile-associated diarrhoea.
    Elliott B; Chang BJ; Golledge CL; Riley TV
    Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Clostridium difficile-associated disease.
    Leffler DA; Lamont JT
    Gastroenterology; 2009 May; 136(6):1899-912. PubMed ID: 19457418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical management of Clostridium difficile-associated disease.
    Miller MA
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S122-8. PubMed ID: 17683016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.